Nicholas Waglechner
McMaster University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicholas Waglechner.
Antimicrobial Agents and Chemotherapy | 2013
Andrew G. McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A. Azad; Alison J. Baylay; Kirandeep Bhullar; Marc J. Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M. King; Kalinka Koteva; Mariya Morar; Michael R. Mulvey; Jonathan S. O'Brien; Andrew C. Pawlowski; Laura J. V. Piddock; Peter Spanogiannopoulos; Arlene D. Sutherland; Irene Tang; Patricia L. Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D. Wright
ABSTRACT The field of antibiotic drug discovery and the monitoring of new antibiotic resistance elements have yet to fully exploit the power of the genome revolution. Despite the fact that the first genomes sequenced of free living organisms were those of bacteria, there have been few specialized bioinformatic tools developed to mine the growing amount of genomic data associated with pathogens. In particular, there are few tools to study the genetics and genomics of antibiotic resistance and how it impacts bacterial populations, ecology, and the clinic. We have initiated development of such tools in the form of the Comprehensive Antibiotic Research Database (CARD; http://arpcard.mcmaster.ca). The CARD integrates disparate molecular and sequence data, provides a unique organizing principle in the form of the Antibiotic Resistance Ontology (ARO), and can quickly identify putative antibiotic resistance genes in new unannotated genome sequences. This unique platform provides an informatic tool that bridges antibiotic resistance concerns in health care, agriculture, and the environment.
Nucleic Acids Research | 2017
Baofeng Jia; Amogelang R. Raphenya; Brian Alcock; Nicholas Waglechner; Peiyao Guo; Kara K. Tsang; Briony A. Lago; Biren M. Dave; Sheldon K. Pereira; Arjun N. Sharma; Sachin Doshi; Mélanie Courtot; Raymond Lo; Laura E. Williams; Jonathan G. Frye; Tariq Elsayegh; Daim Sardar; Erin L. Westman; Andrew C. Pawlowski; Timothy A. Johnson; Fiona S. L. Brinkman; Gerard D. Wright; Andrew G. McArthur
The Comprehensive Antibiotic Resistance Database (CARD; http://arpcard.mcmaster.ca) is a manually curated resource containing high quality reference data on the molecular basis of antimicrobial resistance (AMR), with an emphasis on the genes, proteins and mutations involved in AMR. CARD is ontologically structured, model centric, and spans the breadth of AMR drug classes and resistance mechanisms, including intrinsic, mutation-driven and acquired resistance. It is built upon the Antibiotic Resistance Ontology (ARO), a custom built, interconnected and hierarchical controlled vocabulary allowing advanced data sharing and organization. Its design allows the development of novel genome analysis tools, such as the Resistance Gene Identifier (RGI) for resistome prediction from raw genome sequence. Recent improvements include extensive curation of additional reference sequences and mutations, development of a unique Model Ontology and accompanying AMR detection models to power sequence analysis, new visualization tools, and expansion of the RGI for detection of emergent AMR threats. CARD curation is updated monthly based on an interplay of manual literature curation, computational text mining, and genome analysis.
Nature | 2011
Kirsten I. Bos; Verena J. Schuenemann; G. Brian Golding; Hernán A. Burbano; Nicholas Waglechner; Brian K. Coombes; Joseph B. McPhee; Sharon N. DeWitte; Matthias Meyer; Sarah E. Schmedes; James W. Wood; David J. D. Earn; D. Ann Herring; Peter Bauer; Hendrik N. Poinar; Johannes Krause
Technological advances in DNA recovery and sequencing have drastically expanded the scope of genetic analyses of ancient specimens to the extent that full genomic investigations are now feasible and are quickly becoming standard. This trend has important implications for infectious disease research because genomic data from ancient microbes may help to elucidate mechanisms of pathogen evolution and adaptation for emerging and re-emerging infections. Here we report a reconstructed ancient genome of Yersinia pestis at 30-fold average coverage from Black Death victims securely dated to episodes of pestilence-associated mortality in London, England, 1348–1350. Genetic architecture and phylogenetic analysis indicate that the ancient organism is ancestral to most extant strains and sits very close to the ancestral node of all Y. pestis commonly associated with human infection. Temporal estimates suggest that the Black Death of 1347–1351 was the main historical event responsible for the introduction and widespread dissemination of the ancestor to all currently circulating Y. pestis strains pathogenic to humans, and further indicates that contemporary Y. pestis epidemics have their origins in the medieval era. Comparisons against modern genomes reveal no unique derived positions in the medieval organism, indicating that the perceived increased virulence of the disease during the Black Death may not have been due to bacterial phenotype. These findings support the notion that factors other than microbial genetics, such as environment, vector dynamics and host susceptibility, should be at the forefront of epidemiological discussions regarding emerging Y. pestis infections.
PLOS ONE | 2012
Kirandeep Bhullar; Nicholas Waglechner; Andrew C. Pawlowski; Kalinka Koteva; Eric D. Banks; Michael D. Johnston; Hazel A. Barton; Gerard D. Wright
Antibiotic resistance is a global challenge that impacts all pharmaceutically used antibiotics. The origin of the genes associated with this resistance is of significant importance to our understanding of the evolution and dissemination of antibiotic resistance in pathogens. A growing body of evidence implicates environmental organisms as reservoirs of these resistance genes; however, the role of anthropogenic use of antibiotics in the emergence of these genes is controversial. We report a screen of a sample of the culturable microbiome of Lechuguilla Cave, New Mexico, in a region of the cave that has been isolated for over 4 million years. We report that, like surface microbes, these bacteria were highly resistant to antibiotics; some strains were resistant to 14 different commercially available antibiotics. Resistance was detected to a wide range of structurally different antibiotics including daptomycin, an antibiotic of last resort in the treatment of drug resistant Gram-positive pathogens. Enzyme-mediated mechanisms of resistance were also discovered for natural and semi-synthetic macrolide antibiotics via glycosylation and through a kinase-mediated phosphorylation mechanism. Sequencing of the genome of one of the resistant bacteria identified a macrolide kinase encoding gene and characterization of its product revealed it to be related to a known family of kinases circulating in modern drug resistant pathogens. The implications of this study are significant to our understanding of the prevalence of resistance, even in microbiomes isolated from human use of antibiotics. This supports a growing understanding that antibiotic resistance is natural, ancient, and hard wired in the microbial pangenome.
Nucleic Acids Research | 2015
Bhavjinder K. Dhillon; Matthew R. Laird; Julie A. Shay; Geoffrey L. Winsor; Raymond Lo; Fazmin Nizam; Sheldon K. Pereira; Nicholas Waglechner; Andrew G. McArthur; Morgan G. I. Langille; Fiona S. L. Brinkman
IslandViewer (http://pathogenomics.sfu.ca/islandviewer) is a widely used web-based resource for the prediction and analysis of genomic islands (GIs) in bacterial and archaeal genomes. GIs are clusters of genes of probable horizontal origin, and are of high interest since they disproportionately encode genes involved in medically and environmentally important adaptations, including antimicrobial resistance and virulence. We now report a major new release of IslandViewer, since the last release in 2013. IslandViewer 3 incorporates a completely new genome visualization tool, IslandPlot, enabling for the first time interactive genome analysis and gene search capabilities using synchronized circular, horizontal and vertical genome views. In addition, more curated virulence factors and antimicrobial resistance genes have been incorporated, and homologs of these genes identified in closely related genomes using strict filters. Pathogen-associated genes have been re-calculated for all pre-computed complete genomes. For user-uploaded genomes to be analysed, IslandViewer 3 can also now handle incomplete genomes, with an improved queuing system on compute nodes to handle user demand. Overall, IslandViewer 3 represents a significant new version of this GI analysis software, with features that may make it more broadly useful for general microbial genome analysis and visualization.
Lancet Infectious Diseases | 2014
David M. Wagner; Jennifer Klunk; Michaela Harbeck; Alison M. Devault; Nicholas Waglechner; Jason W. Sahl; Jacob Enk; Dawn N. Birdsell; Melanie Kuch; Candice Y. Lumibao; Debi Poinar; Talima Pearson; Mathieu Fourment; Brian Golding; Julia M. Riehm; David J. D. Earn; Sharon N. DeWitte; Jean Marie Rouillard; Gisela Grupe; Ingrid Wiechmann; James B. Bliska; Paul Keim; Holger C. Scholz; Edward C. Holmes; Hendrik N. Poinar
BACKGROUND Yersinia pestis has caused at least three human plague pandemics. The second (Black Death, 14-17th centuries) and third (19-20th centuries) have been genetically characterised, but there is only a limited understanding of the first pandemic, the Plague of Justinian (6-8th centuries). To address this gap, we sequenced and analysed draft genomes of Y pestis obtained from two individuals who died in the first pandemic. METHODS Teeth were removed from two individuals (known as A120 and A76) from the early medieval Aschheim-Bajuwarenring cemetery (Aschheim, Bavaria, Germany). We isolated DNA from the teeth using a modified phenol-chloroform method. We screened DNA extracts for the presence of the Y pestis-specific pla gene on the pPCP1 plasmid using primers and standards from an established assay, enriched the DNA, and then sequenced it. We reconstructed draft genomes of the infectious Y pestis strains, compared them with a database of genomes from 131 Y pestis strains from the second and third pandemics, and constructed a maximum likelihood phylogenetic tree. FINDINGS Radiocarbon dating of both individuals (A120 to 533 AD [plus or minus 98 years]; A76 to 504 AD [plus or minus 61 years]) places them in the timeframe of the first pandemic. Our phylogeny contains a novel branch (100% bootstrap at all relevant nodes) leading to the two Justinian samples. This branch has no known contemporary representatives, and thus is either extinct or unsampled in wild rodent reservoirs. The Justinian branch is interleaved between two extant groups, 0.ANT1 and 0.ANT2, and is distant from strains associated with the second and third pandemics. INTERPRETATION We conclude that the Y pestis lineages that caused the Plague of Justinian and the Black Death 800 years later were independent emergences from rodents into human beings. These results show that rodent species worldwide represent important reservoirs for the repeated emergence of diverse lineages of Y pestis into human populations. FUNDING McMaster University, Northern Arizona University, Social Sciences and Humanities Research Council of Canada, Canada Research Chairs Program, US Department of Homeland Security, US National Institutes of Health, Australian National Health and Medical Research Council.
Nature Biotechnology | 2013
Maulik Thaker; Wenliang Wang; Peter Spanogiannopoulos; Nicholas Waglechner; Andrew M. King; Ricardo Medina; Gerard D. Wright
Microbially derived natural products are major sources of antibiotics and other medicines, but discovering new antibiotic scaffolds and increasing the chemical diversity of existing ones are formidable challenges. We have designed a screen to exploit the self-protection mechanism of antibiotic producers to enrich microbial libraries for producers of selected antibiotic scaffolds. Using resistance as a discriminating criterion we increased the discovery rate of producers of both glycopeptide and ansamycin antibacterial compounds by several orders of magnitude in comparison with historical hit rates. Applying a phylogeny-based screening filter for biosynthetic genes enabled the binning of producers of distinct scaffolds and resulted in the discovery of a glycopeptide antibacterial compound, pekiskomycin, with an unusual peptide scaffold. This strategy provides a means to readily sample the chemical diversity available in microbes and offers an efficient strategy for rapid discovery of microbial natural products and their associated biosynthetic enzymes.
The New England Journal of Medicine | 2014
Alison M. Devault; G. Brian Golding; Nicholas Waglechner; Jacob Enk; Melanie Kuch; Joseph H. Tien; Mang Shi; David N. Fisman; Anna N. Dhody; Stephen Forrest; Kirsten I. Bos; David J. D. Earn; Edward C. Holmes; Hendrik N. Poinar
In the 19th century, there were several major cholera pandemics in the Indian subcontinent, Europe, and North America. The causes of these outbreaks and the genomic strain identities remain a mystery. We used targeted high-throughput sequencing to reconstruct the Vibrio cholerae genome from the preserved intestine of a victim of the 1849 cholera outbreak in Philadelphia, part of the second cholera pandemic. This O1 biotype strain has 95 to 97% similarity with the classical O395 genome, differing by 203 single-nucleotide polymorphisms (SNPs), lacking three genomic islands, and probably having one or more tandem cholera toxin prophage (CTX) arrays, which potentially affected its virulence. This result highlights archived medical remains as a potential resource for investigations into the genomic origins of past pandemics.
Frontiers in Microbiology | 2015
Luca Freschi; Julie Jeukens; Irena Kukavica-Ibrulj; Brian Boyle; Marie Josée Dupont; Jérôme Laroche; Stéphane Larose; Halim Maaroufi; Joanne L. Fothergill; Matthew Moore; Geoffrey L. Winsor; Shawn D. Aaron; Jean Barbeau; Scott C. Bell; Jane L. Burns; Miguel Cámara; André M. Cantin; Steve J. Charette; Ken Dewar; Eric Déziel; Keith Grimwood; Robert E. W. Hancock; Joe J. Harrison; Stephan Heeb; Lars Jelsbak; Baofeng Jia; D. Kenna; Timothy J. Kidd; Jens Klockgether; Joseph S. Lam
The International Pseudomonas aeruginosa Consortium is sequencing over 1000 genomes and building an analysis pipeline for the study of Pseudomonas genome evolution, antibiotic resistance and virulence genes. Metadata, including genomic and phenotypic data for each isolate of the collection, are available through the International Pseudomonas Consortium Database (http://ipcd.ibis.ulaval.ca/). Here, we present our strategy and the results that emerged from the analysis of the first 389 genomes. With as yet unmatched resolution, our results confirm that P. aeruginosa strains can be divided into three major groups that are further divided into subgroups, some not previously reported in the literature. We also provide the first snapshot of P. aeruginosa strain diversity with respect to antibiotic resistance. Our approach will allow us to draw potential links between environmental strains and those implicated in human and animal infections, understand how patients become infected and how the infection evolves over time as well as identify prognostic markers for better evidence-based decisions on patient care.
eLife | 2016
Kirsten I. Bos; Alexander Herbig; Jason W. Sahl; Nicholas Waglechner; Mathieu Fourment; Stephen Forrest; Jennifer Klunk; Verena J. Schuenemann; Debi Poinar; Melanie Kuch; G. Brian Golding; Olivier Dutour; Paul Keim; David M. Wagner; Edward C. Holmes; Johannes Krause; Hendrik N. Poinar
The 14th–18th century pandemic of Yersinia pestis caused devastating disease outbreaks in Europe for almost 400 years. The reasons for plague’s persistence and abrupt disappearance in Europe are poorly understood, but could have been due to either the presence of now-extinct plague foci in Europe itself, or successive disease introductions from other locations. Here we present five Y. pestis genomes from one of the last European outbreaks of plague, from 1722 in Marseille, France. The lineage identified has not been found in any extant Y. pestis foci sampled to date, and has its ancestry in strains obtained from victims of the 14th century Black Death. These data suggest the existence of a previously uncharacterized historical plague focus that persisted for at least three centuries. We propose that this disease source may have been responsible for the many resurgences of plague in Europe following the Black Death. DOI: http://dx.doi.org/10.7554/eLife.12994.001